Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

NASA's first ground-based Galactic Cosmic Ray Simulator: Enabling a new era in space radiobiology research.

Tytuł:
NASA's first ground-based Galactic Cosmic Ray Simulator: Enabling a new era in space radiobiology research.
Autorzy:
Simonsen LC; NASA Langley Research Center, Hampton, Virginia, United States of America.
Slaba TC; NASA Langley Research Center, Hampton, Virginia, United States of America.
Guida P; Brookhaven National Laboratory, Brookhaven, New York, United States of America.
Rusek A; Brookhaven National Laboratory, Brookhaven, New York, United States of America.
Źródło:
PLoS biology [PLoS Biol] 2020 May 19; Vol. 18 (5), pp. e3000669. Date of Electronic Publication: 2020 May 19 (Print Publication: 2020).
Typ publikacji:
Journal Article; Research Support, U.S. Gov't, Non-P.H.S.
Język:
English
Imprint Name(s):
Original Publication: San Francisco, CA : Public Library of Science, [2003]-
MeSH Terms:
Cosmic Radiation*
Space Simulation*
Radiobiology/*instrumentation
Animals ; Humans ; Mice ; Rats ; Space Flight
References:
Science. 2013 May 31;340(6136):1080-4. (PMID: 23723233)
Phys Med Biol. 2003 May 21;48(10):1239-62. (PMID: 12812444)
Radiat Res. 2006 Sep;166(3):488-94. (PMID: 16953667)
Phys Med Biol. 2004 Dec 7;49(23):5203-16. (PMID: 15656272)
Life Sci Space Res (Amst). 2020 May;25:107-118. (PMID: 32414484)
Life Sci Space Res (Amst). 2016 Feb;8:38-51. (PMID: 26948012)
Life Sci Space Res (Amst). 2017 Aug;14:18-28. (PMID: 28887939)
Life Sci Space Res (Amst). 2016 Nov;11:18-23. (PMID: 27993189)
Radiat Res. 2008 Jul;170(1):127-38. (PMID: 18582161)
Life Sci Space Res (Amst). 2019 Aug;22:98-124. (PMID: 31421854)
Radiat Prot Dosimetry. 2019 May 1;183(1-2):203-212. (PMID: 30535099)
Front Oncol. 2015 Jun 04;5:122. (PMID: 26090339)
Radiat Res. 2017 Aug;188(2):191-203. (PMID: 28613990)
Life Sci Space Res (Amst). 2016 Feb;8:52-67. (PMID: 26948013)
NPJ Microgravity. 2018 Apr 3;4:8. (PMID: 29644336)
Entry Date(s):
Date Created: 20200520 Date Completed: 20200720 Latest Revision: 20200720
Update Code:
20240105
PubMed Central ID:
PMC7236977
DOI:
10.1371/journal.pbio.3000669
PMID:
32428004
Czasopismo naukowe
With exciting new NASA plans for a sustainable return to the moon, astronauts will once again leave Earth's protective magnetosphere only to endure higher levels of radiation from galactic cosmic radiation (GCR) and the possibility of a large solar particle event (SPE). Gateway, lunar landers, and surface habitats will be designed to protect crew against SPEs with vehicle optimization, storm shelter concepts, and/or active dosimetry; however, the ever penetrating GCR will continue to pose the most significant health risks especially as lunar missions increase in duration and as NASA sets its aspirations on Mars. The primary risks of concern include carcinogenesis, central nervous system (CNS) effects resulting in potential in-mission cognitive or behavioral impairment and/or late neurological disorders, degenerative tissue effects including circulatory and heart disease, as well as potential immune system decrements impacting multiple aspects of crew health. Characterization and mitigation of these risks requires a significant reduction in the large biological uncertainties of chronic (low-dose rate) heavy-ion exposures and the validation of countermeasures in a relevant space environment. Historically, most research on understanding space radiation-induced health risks has been performed using acute exposures of monoenergetic single-ion beams. However, the space radiation environment consists of a wide variety of ion species over a broad energy range. Using the fast beam switching and controls systems technology recently developed at the NASA Space Radiation Laboratory (NSRL) at Brookhaven National Laboratory, a new era in radiobiological research is possible. NASA has developed the "GCR Simulator" to generate a spectrum of ion beams that approximates the primary and secondary GCR field experienced at human organ locations within a deep-space vehicle. The majority of the dose is delivered from protons (approximately 65%-75%) and helium ions (approximately 10%-20%) with heavier ions (Z ≥ 3) contributing the remainder. The GCR simulator exposes state-of-the art cellular and animal model systems to 33 sequential beams including 4 proton energies plus degrader, 4 helium energies plus degrader, and the 5 heavy ions of C, O, Si, Ti, and Fe. A polyethylene degrader system is used with the 100 MeV/n H and He beams to provide a nearly continuous distribution of low-energy particles. A 500 mGy exposure, delivering doses from each of the 33 beams, requires approximately 75 minutes. To more closely simulate the low-dose rates found in space, sequential field exposures can be divided into daily fractions over 2 to 6 weeks, with individual beam fractions as low as 0.1 to 0.2 mGy. In the large beam configuration (60 × 60 cm2), 54 special housing cages can accommodate 2 to 3 mice each for an approximately 75 min duration or 15 individually housed rats. On June 15, 2018, the NSRL made a significant achievement by completing the first operational run using the new GCR simulator. This paper discusses NASA's innovative technology solution for a ground-based GCR simulator at the NSRL to accelerate our understanding and mitigation of health risks faced by astronauts. Ultimately, the GCR simulator will require validation across multiple radiogenic risks, endpoints, doses, and dose rates.
Competing Interests: The authors have declared that no competing interests exist.
Zaloguj się, aby uzyskać dostęp do pełnego tekstu.

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies